Literature DB >> 6541272

[Antithrombin III changes following myocardial infarct].

G Oehler, M Büdinger, D Heinrich, T Schöndorf.   

Abstract

The antithrombin III (AT III) activity and the AT III concentration were investigated in 62 consecutive patients with acute myocardial infarction (AMI). To identify the reactant pattern of AT III in postaggressive situations, we also determined labile and acute phase proteins. Firstly, 29 patients were nourished orally and then 33 patients were fed by i.v. hyperalimentation (additional caloric intake of approximately 1,000 cal). AT III activities and concentrations as well as prealbumin and retinol-binding protein decreased concomittantly and significantly whereas haptoglobin, C-reactive protein and fibrinogen increased significantly after AMI. The changes cannot be interpreted as being alterations of the haematocrit. The alterations of AT III correlated significantly with the changes of labile proteins but not with the acute phase reactant proteins. The AT III decrease in the postinfarctional phase may promote a prethrombotic state. In addition it can be concluded from our results that AT III reacts as (nutritive-dependent) labile protein, which is lowered in postaggressive situation and does not increase as an acute phase reactant. This is in accordance with results from recent animal experiments.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6541272     DOI: 10.1007/bf01711862

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  16 in total

1.  Antithrombin III and heparin.

Authors:  V V Kakkar; P G Bentley; M F Scully; I R MacGregor; N A Jones; P J Webb
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

2.  Heparin cofactor activity measured with an amidolytic method.

Authors:  O R Odegard; M Lie; U Abildgaard
Journal:  Thromb Res       Date:  1975-04       Impact factor: 3.944

Review 3.  Antithrombin III deficiency and thromboembolism.

Authors:  E Thaler; K Lechner
Journal:  Clin Haematol       Date:  1981-06

4.  Study of daily caloric intake of patients in the coronary intensive care unit.

Authors:  J Feldschuh; Y Z Yuceoglu
Journal:  Angiology       Date:  1975-04       Impact factor: 3.619

5.  The effect of total hip replacement and general surgery on antithrombin III in relation to venous thrombosis.

Authors:  S N Gitel; E A Salvati; S Wessler; H J Robinson; M H Worth
Journal:  J Bone Joint Surg Am       Date:  1979-07       Impact factor: 5.284

6.  Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease.

Authors:  R Losito; H Gattiker; G Bilodeau; N Verville; B Longpré
Journal:  J Lab Clin Med       Date:  1981-02

7.  Net biosynthesis of antithrombin III by the isolated rat liver perfused for 12--24 hours. Compared with rat fibrinogen and alpha-2 (acute-phase) globulin, antithrombin III is not an acute phase protein.

Authors:  M R Owens; L L Miller
Journal:  Biochim Biophys Acta       Date:  1980-01-03

8.  Soluble plasma fibrin and platelet prostaglandin endoperoxides following myocardial infarction.

Authors:  F R Matthias
Journal:  Haemostasis       Date:  1978

9.  Acquired antithrombin III deficiency in patients with glomerular proteinuria.

Authors:  E Thaler; E Balzar; H Kopsa; W F Pinggera
Journal:  Haemostasis       Date:  1978

10.  [Perioperative plasma antithrombin activity with "low-dose" heparin prophylaxis. Perioperatively acquired antithrombin III deficiency as a cause for the failure of heparin prophylaxis?].

Authors:  J Kussmann; H Hirche; R Sengupta
Journal:  Dtsch Med Wochenschr       Date:  1983-03-25       Impact factor: 0.628

View more
  1 in total

1.  [Immunologic and functional protein C determination in various internal diseases].

Authors:  K H Zurborn; H Broers; W Kirch; N Jäger; H D Bruhn
Journal:  Klin Wochenschr       Date:  1987-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.